Shanghai readies for biggest pharma show
Poised to become the 5th largest in the world by 2010, the Chinese pharmaceutical market is growing at a pace of around 20% each year
China Pharma to touch $24 bn by 2010
China's pharmaceutical industry ranks seventh in the world and is expected to become the world's 5th largest by 2010 with pharmaceutical sales of US$24 billion
CPhI China 2005: A review
Visitors for China's foremost ingredients show CPhI China has been growing steadily year after year
P-MEC - an added attraction
The organisers forcast at least 14,000 visitors with an opportunity to see over 1,000 exhibitors - more than 20% above the 756 exhibitors at the 2005 show, for the CPhI China's sixth edition.
India to ease norms on Chinese investments
While India and China are celebrating year 2006 as India-China Friendship year, the Indian Government is planning to ease the restrictions on Chinese companies investing in India, it is learnt.
Low value Chinese imports hit India's API sector
The Chinese bulk drugs are cheaper when compared to Indian products because of economies of scale, tariffs of power and tax structure etc
China: A preferred drug development outsourcing market
China with the advantages such as large patient pool, skilled professionals and government support towards pharmaceutical research is drawing the attention of pharmaceutical companies in the Western world.
Overseas industry lauds China's IPR efforts
The Quality Brands Protection Committee (QBPC) under the China Association of Enterprises with Foreign Investment (CAEFI), an industry group of 142 international companies operating in China
NCPC-Orchid posts US$ 11m growth
NCPC Orchid Pharmaceuticals Co. Ltd., the 50:50 joint venture of Chennai based Orchid Chemicals and Pharmaceuticals and the North China Pharmaceutical Corporation (NCPC)
'China's pharma exports to India have grown phenomenally'
China Pharmaceutical Industry Association (CPIA) was founded on September 10,1988.
India to trial Chinese JE vaccine
Soon the National Institute of Virology (NIV) at Pune will be conducting clinical trials of the Chinese made SA14-14-2 vaccine for Japanese Encephalitis (JE)
China's TCM firm launched in ASE
American Oriental Bioengineering, Inc. (AOBO), a listed company in the American Stock Exchange has recently bought out the Guangxi LingFeng Pharmaceutical Co., Ltd.
Mchem helps Matrix to firm up ARV portfolio
Based in Xiamen, on the East coast of China, Mchem group manufactures pharmaceutical products ranging from basic chemicals,intermediates, active pharmaceutical ingredients and finished dosage forms with a group turnover of about US$ 35 million
Hong Kong varsity spots new anti-malarial
Hong Kong University of Science and Technology said that its researchers have invented new anti-malarial drug.
Copyright © Saffron Media Pvt. Ltd.